(Q42532004)

1 November 2017

The relationship between debrisoquine oxidation phenotype and the pharmacokinetics and pharmacodynamics of propranolol (English)

1 reference

1 November 2017

1 reference

1 reference

Lennard MS

1

1 reference

1 November 2017

Jackson PR

2

1 reference

1 November 2017

Freestone S

3

1 reference

1 November 2017

Tucker GT

4

1 reference

1 November 2017

Ramsay LE

5

1 reference

1 November 2017

Woods HF

6

1 reference

1 November 2017

language of work or name

English

0 references

publication date

1 June 1984

1 reference

British Journal of Clinical Pharmacology

1 November 2017

1 reference

1 November 2017

17

1 reference

1 November 2017

679-685

1 reference

1 November 2017

6

1 reference

Plasma levels of (+) and (-)-propranolol and 4-hydroxypropranolol after administration of racemic (+/-)-propranolol in man

1 November 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1463425

Interaction of phenobarbital with propranolol in the dog. 3. Beta blockade

28 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1463425

Defective metabolism of metoprolol in poor hydroxylators of debrisoquine

28 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1463425

Defective hydroxylation of bufuralol associated with side-effects of the drug in poor metabolisers [letter]

28 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1463425

Plasma propranolol levels in adults With observations in four children

28 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1463425

Pharmacology of 4-hydroxypropranolol, a metabolite of propranolol

28 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1463425

Hepatic clearance of drugs. I. Theoretical considerations of a "well-stirred" model and a "parallel tube" model. Influence of hepatic blood flow, plasma and blood cell binding, and the hepatocellular enzymatic activity on hepatic drug clearance

28 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1463425

Effect of route of administration on the relationship between -adrenergic blockade and plasma propranolol level.

28 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1463425

Effect of dose and uremia on plasma and urine profiles of propranolol metabolites

28 May 2018

1 reference

12 December 2020

An automated HPLC method for the assay of propranolol and its basic metabolites in plasma and urine

1 reference

12 December 2020

Oxidation phenotype--a major determinant of metoprolol metabolism and response

1 reference

12 December 2020

Pharmacokinetic and clinical consequences of the genetic polymorphism of oxidation

1 reference

12 December 2020

Dose-dependent elimination of propranolol and its major metabolites in humans

1 reference

12 December 2020

Identification of major sulfate conjugates in the metabolism of propranolol in dog and man

1 reference

12 December 2020

Stereoselective binding of propranolol to human plasma, alpha 1-acid glycoprotein, and albumin

1 reference

12 December 2020

10.1111/J.1365-2125.1984.TB02403.X

Identifiers

DOI

1 reference

1 November 2017

1 reference

1 November 2017

1 reference